title: Nicotinic interactions with antipsychotic drugs, models of schizophrenia and impacts on cognitive function.
abstract: People with schizophrenia often have substantial cognitive impairments, which may be related to nicotinic receptor deficits, (alpha7 and alpha4beta2), documented in the brains of people with schizophrenia. The large majority of people with schizophrenia smoke cigarettes. Thus, nicotinic interactions with antipsychotic drugs are widespread. Complementary co-therapies of novel nicotinic ligands are being developed to add to antipsychotic therapy to treat the cognitive impairment of schizophrenia. Thus, it is critical to understand the interaction between nicotinic treatments and antipsychotic drugs. Nicotinic interactions with antipsychotic drugs, are complex since both nicotine and antipsychotics have complex actions. Nicotine stimulates and desensitizes nicotinic receptors of various subtypes and potentiates the release of different neurotransmitters. Antipsychotics also act on a verity of receptor systems. For example, clozapine acts as an antagonist at a variety of neurotransmitter receptors such as those for dopamine, serotonin, norepinepherine and histamine. In a series of studies, we have found that in normally functioning rats, moderate doses of clozapine impair working memory and that clozapine blocks nicotine-induced memory and attentional improvement. Clozapine and nicotine can attenuate each other's beneficial effects in reversing the memory impairment caused by the psychototmimetic drug dizocilpine. A key to the clozapine-induced attenuation of nicotine-induced cognitive improvement appears to be its 5HT(2) antagonist properties. The selective 5HT(2) antagonist ketanserin has a similar action of blocking nicotine-induced memory and attentional improvements. It is important to consider the interactions between nicotinic and antipsychotic drugs to develop the most efficacious treatment for cognitive improvement in people with schizophrenia.
authors: Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, NC 27710, USA. edlevin@duke.edu
authors: Edward D
authors: ED
authors: Levin
authors: Amir H
authors: AH
authors: Rezvani
mesh_terms: D000818:Animals; D014150:Antipsychotic Agents / Q000494:pharmacology*; D003071:Cognition / Q000187:drug effects*; D003072:Cognition Disorders / Q000188:drug therapy / Q000209:etiology; D004347:Drug Interactions; D006801:Humans; D009538:Nicotine / Q000494:pharmacology* / Q000627:therapeutic use; D011978:Receptors, Nicotinic / Q000502:physiology; D012559:Schizophrenia / Q000188:drug therapy*
chemical_list: D014150:Antipsychotic Agents; D011978:Receptors, Nicotinic; D009538:Nicotine
references: Biol Psychiatry. 2002 Oct 1;52(7):721-8
references: 12372663
references: Neuropsychopharmacology. 2002 Oct;27(4):534-41
references: 12377390
references: Arch Gen Psychiatry. 2002 Dec;59(12):1085-96
references: 12470124
references: Psychopharmacology (Berl). 2003 Feb;165(4):386-96
references: 12459928
references: Neuropsychopharmacology. 2003 Feb;28(2):216-25
references: 12589374
references: Eur J Pharmacol. 2003 Mar 28;465(1-2):83-90
references: 12650836
references: Psychiatry Res. 2003 Mar 25;117(3):223-36
references: 12686365
references: Neuropharmacology. 2003 Jun;44(8):1054-67
references: 12763099
references: Pharmacol Biochem Behav. 2003 Aug;76(1):133-9
references: 13679226
references: Neuropsychopharmacology. 2003 Oct;28(10):1770-7
references: 12865892
references: Psychopharmacology (Berl). 2003 Sep;169(3-4):332-9
references: 12759805
references: Pharmacol Biochem Behav. 1997 Apr;56(4):789-95
references: 9130306
references: Neuropsychopharmacology. 1997 Jun;16(6):433-7
references: 9165499
references: Am J Psychiatry. 1997 Jun;154(6):799-804
references: 9167507
references: Drugs Aging. 1997 Sep;11(3):206-28
references: 9303280
references: Int Clin Psychopharmacol. 1997 Sep;12 Suppl 4:S29-36
references: 9352344
references: Pharmacol Biochem Behav. 1997 Dec;58(4):899-902
references: 9408193
references: J Clin Psychopharmacol. 1998 Apr;18(2 Suppl 1):12S-9S
references: 9555611
references: Schizophr Bull. 1998;24(2):189-202
references: 9613620
references: Psychiatr Serv. 1998 Jul;49(7):925-8
references: 9661227
references: Pharmacol Biochem Behav. 1998 Nov;61(3):335-40
references: 9768569
references: Am J Psychiatry. 1998 Nov;155(11):1490-501
references: 9812108
references: Schizophr Res. 1999 May 4;37(1):1-11
references: 10227103
references: J Clin Psychiatry. 1999;60 Suppl 12:24-9
references: 10372607
references: Schizophr Bull. 1999;25(2):233-55
references: 10416729
references: Neuroreport. 1999 Jun 3;10(8):1779-82
references: 10501574
references: J Psychopharmacol. 2004 Dec;18(4):457-74
references: 15582913
references: IDrugs. 2004 Dec;7(12):1096-103
references: 15599803
references: Psychopharmacology (Berl). 1999 Jan;141(3):267-78
references: 10027508
references: Eur Psychiatry. 2005 Jan;20(1):50-4
references: 15642444
references: Am J Psychiatry. 2005 Feb;162(2):386-8
references: 15677607
references: Am J Psychiatry. 2005 Feb;162(2):391-3
references: 15677609
references: J Pharmacol Exp Ther. 2005 Mar;312(3):1213-22
references: 15523001
references: Br J Psychiatry. 2005 Mar;186:215-21
references: 15738502
references: Pharmacol Biochem Behav. 2005 Mar;80(3):453-61
references: 15740788
references: Pharmacol Biochem Behav. 2005 Oct;82(2):289-92
references: 16185760
references: Psychopharmacology (Berl). 2006 Jan;183(4):500-5
references: 16292589
references: Psychopharmacology (Berl). 2006 Mar;184(3-4):523-39
references: 16220335
references: Prog Neuropsychopharmacol Biol Psychiatry. 2006 Mar;30(2):190-7
references: 16310917
references: Neuropharmacology. 2007 Feb;52(2):387-94
references: 17161853
references: J Neurosci. 2007 Feb 21;27(8):1964-72
references: 17314292
references: Int J Neuropsychopharmacol. 2008 Feb;11(1):63-70
references: 17295931
references: Curr Top Med Chem. 2004;4(3):267-82
references: 14754447
references: Eur J Pharmacol. 2004 Feb 20;486(2):175-82
references: 14975706
references: Acta Psychiatr Scand. 2004 Apr;109(4):313-7; discussion 317-8
references: 15008806
references: Curr Opin Pharmacol. 2004 Feb;4(1):36-46
references: 15018837
references: Synapse. 2004 May;52(2):114-22
references: 15034917
references: Biol Psychiatry. 2004 Apr 15;55(8):850-8
references: 15050867
references: Curr Drug Targets CNS Neurol Disord. 2004 Apr;3(2):123-30
references: 15078187
references: Prog Neuropsychopharmacol Biol Psychiatry. 2004 May;28(3):505-16
references: 15093958
references: Neuropsychopharmacology. 2004 May;29(5):891-900
references: 14970827
references: J Med Chem. 2005 Apr 7;48(7):2678-86
references: 15801858
references: Psychopharmacology (Berl). 2005 May;179(3):521-8
references: 15682310
references: Schizophr Res. 2003 Dec 1;65(1):47-55
references: 14623374
references: Neuropsychopharmacology. 2003 Dec;28(12):2184-91
references: 12968127
references: Psychopharmacology (Berl). 2004 Jun;174(1):54-64
references: 15205879
references: Neuropsychopharmacology. 2004 Jul;29(7):1378-85
references: 15138435
references: Am J Psychiatry. 2004 Jul;161(7):1219-23
references: 15229054
references: Psychopharmacology (Berl). 2004 Jul;174(3):334-40
references: 14997272
references: Behav Brain Res. 2004 Aug 31;153(2):419-22
references: 15265637
references: Curr Med Res Opin. 2004 Jul;20(7):1057-74
references: 15265251
references: Neuropsychopharmacology. 2004 Aug;29(8):1522-6
references: 15100704
references: Neuropsychobiology. 2004;50(2):124-7
references: 15292665
references: Science. 1983 Apr 8;220(4593):214-6
references: 6828889
references: J Pharmacol Exp Ther. 1983 Sep;226(3):817-25
references: 6887012
references: Am J Psychiatry. 1986 Aug;143(8):993-7
references: 3487983
references: Pharmacol Biochem Behav. 1987 Jan;26(1):1-6
references: 3562481
references: Behav Neural Biol. 1988 Mar;49(2):234-9
references: 3365189
references: Psychopharmacology (Berl). 1988;96(2):253-7
references: 2906749
references: Prog Brain Res. 1989;79:157-63
references: 2573910
references: Am J Psychiatry. 1993 Dec;150(12):1856-61
references: 8238642
references: Biol Psychiatry. 1993 Nov 15;34(10):702-12
references: 8292674
references: J Clin Psychiatry. 1994 Sep;55 Suppl B:88-90
references: 7525543
references: Brain Res. 1995 Mar 20;674(2):252-9
references: 7796104
references: Biol Psychiatry. 1995 Apr 15;37(8):550-2
references: 7619979
references: Psychopharmacology (Berl). 1995 May;119(1):124-6
references: 7675943
references: Science. 1995 Sep 22;269(5231):1692-6
references: 7569895
references: Biol Psychiatry. 1995 Jul 1;38(1):22-33
references: 7548469
references: Eur J Pharmacol. 1995 Aug 15;281(3):241-50
references: 8521906
references: J Clin Psychiatry. 1996;57 Suppl 9:62-5
references: 8823353
references: Neuropsychopharmacology. 1996 Aug;15(2):152-62
references: 8840351
references: Neuropsychopharmacology. 1996 Mar;14(3 Suppl):27S-33S
references: 8866741
references: Neuropsychopharmacology. 1996 Oct;15(4):361-9
references: 8887990
references: Neuropsychopharmacology. 1996 Nov;15(5):429-36
references: 8914115
references: Psychopharmacology (Berl). 1996 Mar;124(1-2):126-33
references: 8935807
references: J Clin Psychiatry. 1996;57 Suppl 11:31-9
references: 8941169
references: Schizophr Res. 2005 Jul 1;76(1):67-72
references: 15927799
references: Arch Gen Psychiatry. 2005 Jun;62(6):649-59
references: 15939842
references: Neurotoxicol Teratol. 2005 May-Jun;27(3):459-64
references: 15939205
references: Schizophr Res. 2005 Jul 15;76(2-3):135-57
references: 15949648
references: Pharmacol Biochem Behav. 2005 Jul;81(3):575-84
references: 15936063
references: Isr J Psychiatry Relat Sci. 2005;42(1):33-44
references: 16134405
references: Psychopharmacology (Berl). 2005 Oct;182(2):214-9
references: 16001118
references: Actas Esp Psiquiatr. 1999 Sep-Oct;27(5):341-6
references: 10545667
references: Eur J Pharmacol. 2000 Mar 30;393(1-3):51-8
references: 10770997
references: Eur J Pharmacol. 2000 Mar 30;393(1-3):141-6
references: 10771007
references: Eur J Pharmacol. 2000 Mar 30;393(1-3):237-42
references: 10771019
references: Behav Pharmacol. 1999 Nov;10(6-7):675-80
references: 10780509
references: Neurosci Lett. 2000 Jun 23;287(2):109-12
references: 10854724
references: Am J Med Genet. 2000 Apr 3;96(2):173-7
references: 10893492
references: Exp Aging Res. 2000 Oct-Dec;26(4):323-36
references: 11091939
references: Behav Brain Res. 2000 Dec 20;117(1-2):197-208
references: 11099773
references: Biol Psychiatry. 2001 Feb 1;49(3):258-67
references: 11230877
references: J Chem Neuroanat. 2000 Dec;20(3-4):299-306
references: 11207427
references: Neuropsychopharmacology. 2002 Jan;26(1):75-85
references: 11751034
references: Neuropsychopharmacology. 2002 Sep;27(3):479-97
references: 12225705